HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 4099Erstellt: 4. November 2026
Metharbital
Methylbarbital · an23 · AN 23 · sch412 · Gemonal · Gemonil · Gemonit · Sch 412
https://huagongshe.com/de/chemical/4099
Identifikatoren & physikalische Daten
| CAS No. | 50-11-3 |
|---|
| Summenformel | C9H14N2O3 |
|---|
| Durchschnittliche Molmasse | 198,22 g/mol |
|---|
| Monoisotopische Masse | 198,10044231 g/mol |
|---|
| SMILES | CCC1(CC)C(=O)NC(=O)N(C)C1=O |
|---|
| InChIKey | FWJKNZONDWOGMI-UHFFFAOYSA-N |
|---|
| PubChem CID | 4099 |
|---|
| ChEMBL | CHEMBL450 |
|---|
| ChEBI | CHEBI:31827 |
|---|
| EC No. | 200-011-2 |
|---|
| DTXSID | DTXSID6023280 |
|---|
| Lokaler Name | Metharbital |
|---|
Chemische & physikalische Eigenschaften
| XLogP | 1,2 |
|---|
| Polarare Oberfläche (TPSA) | 66,5 |
|---|
| H-Brücken-Donoren | 1 |
|---|
| H-Brücken-Akzeptoren | 3 |
|---|
| Frei drehbare Bindungen | 2 |
|---|
| Schwere Atome | 14 |
|---|
| Formalladung | 0 |
|---|
| Komplexität | 294 |
|---|
| Arzneimittel | DEA NFLIS-Drug Category -> Depressants and TranquilizersPharmaceuticals -> Listed in ZINC15Pharmaceuticals -> Barbiturates |
|---|
| SpringerMaterials Properties | Nuclear quadrupole resonance spectroscopy |
|---|
| LogP (Verteilungskoeffizient) | 0.61.15 |
|---|
| Löslichkeit | 1.95e+01 g/LDMSO (Slightly), Methanol (Slightly)987mg/L(room temperature) |
|---|
| Human Drugs | FDA approved drugs -> Active ingredient |
|---|
| Schmelzpunkt | 150.5 °C155° |
|---|
| Physical Description | Solid |
|---|
| Dissociation Constants | 8.01 (at 25 °C) |
|---|
| Siedepunkt | 335.53°C (rough estimate) |
|---|
| Dichte | 1.2119 (rough estimate) |
|---|
| Brechungsindex | 1.4922 (estimate) |
|---|
| pKa (Säurekonstante) | 8.45: Fox, Shugar, Bull. Soc. Chim. Belg. 61, 44 (1952) |
|---|
| Aggregatzustand | Solid |
|---|
| Farbe | White to Off-White |
|---|
Sicherheit & Vorschriften
| GHS-Einstufung | WarningH400 (100%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]P273, P391, and P501 (click each P-code to see the statement)The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. |
|---|
| Gesundheitliche Auswirkungen | May cause a potentially dangerous rash that may develop into Stevens Johnson syndrome, an extremely rare but potentially fatal skin disease. |
|---|
| Toxizitätsübersicht | Metharbital binds at a distinct binding site associated with a Cl<sup>-</sup> ionopore at the GABA<sub>A</sub> receptor, increasing the duration of time for which the Cl<sup>-</sup> ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged. All of these effects are associated with marked decreases in GABA-sensitive neuronal calcium conductance (gCa). The net result of barbiturate action is acute potentiation of inhibitory GABAergic tone. Barbiturates also act through potent (if less well characterized) and direct inhibition of excitatory AMPA-type glutamate receptors, resulting in a profound suppression of glutamatergic neurotransmission. |
|---|
| Signs and Symptoms | Signs of overdose include confusion (severe), decrease in or loss of reflexes, drowsiness (severe), fever, irritability (continuing), low body temperature, poor judgment, shortness of breath or slow or troubled breathing, slow heartbeat, slurred speech, staggering, trouble in sleeping, unusual movements of the eyes, weakness (severe). |
|---|
| Carcinogen Classification | No indication of carcinogenicity to humans (not listed by IARC). |
|---|
| UN-Transportnummer | 3249 |
|---|
| Gefahrenklasse | 6.1(b) |
|---|
| Verpackungsgruppe | III |
|---|